Expression of the matrix receptor CD44v5 on chondrocytes changes with osteoarthritis: An experimental investigation in the rabbit

Annals of the Rheumatic Diseases

Volumn 65, Issue 1, 2006, Pages 105-108

  Tibesku, C O ^a,c   Szuwart, T ^b   Ocken, S A ^a   Skwara, A ^a   Fuchs, S ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; CD44V5 ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT;

ANIMALS; ANTIGENS, CD44; ARTHRITIS, EXPERIMENTAL; CHONDROCYTES; FEMALE; HYALINE CARTILAGE; IMMUNOENZYME TECHNIQUES; OSTEOARTHRITIS; RABBITS; SEVERITY OF ILLNESS INDEX;

EID: 29144458863     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2004.034694     Document Type: Article

References (15)

1. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B. CD44 is the principal cell surface receptor for hyaluronate. Cell 1990;61:1303-13.
2. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C, et al. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111:2765-74.
3. Bajorath J. Molecular organization, structural features, and ligand binding characteristics of CD44, a highly variable cell surface glycoprotein with multiple functions. Proteins 2000;39:103-11.
4. Hale LP, Haynes BF, McCachren SS. Expression of CD44 variants in human inflammatory synovitis. J Clin Immunol 1995;15:300-11.
5. Salter DM, Godolphin JL, Gourlay MS, Lawson MF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402.
6. Fuchs S, Dankbar B, Wildenau G, Goetz W, Lohmann CH, Tibesku CO. Expression of the CD44 variant isoform 5 in the human osteoarthritic knee joint: correlation with radiological, histomorphological, and biochemical parameters. J Orthop Res 2004;22:774-80.
7. Fuchs S, Rolauffs B, Arndt S, Tibesku CO, Prehm P. CD44H and the isoforms CD44v5 and CD44v6 in the synovial fluid of the osteoarthritic human knee joint. Osteoarthritis Cartilage 2003;11:839-44.
8. Knudson W, Loeser RF. CD44 and integrin matrix receptors participate in cartilage homeostasis. Cell Mol Life Sci 2002;59:36-44.
9. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53:523-37.
10. Ostergaard K, Salter DM, Andersen CB, Petersen J, Bendtzen K. CD44 expression is up-regulated in the deep zone of osteoarthritic cartilage from human femorai heads. Histopathology 1997;31:451-9.
11. Chow G, Knudson CB, Homandberg G, Knudson W. Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem 1995;270:27734-41.
12. Sleeman J, Rudy W, Hofmann M, Moll J, Herrlich P, Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. J Cell Biol 1996;135:1139-50.
13. Feyertag J, Haberhauer G, Skoumal M, Kittl EM, Bauer K, Dunky A. [Serum soluble CD44 isoform variant 5 level in patients with seropositive rheumatoid arthritis treated with cyclosporin A]. Acta Med Austriaca 2000;27:156-9.
14. Haberhauer G, Kittl EM. Soluble CD44 isoform variant-5 (sCD44v5): a new serum marker in rheumatoid arthritis? J Rheumatol 1998;25:1442-4.
15. Kittl EM, Haberhauer G, Ruckser R, Selleny S, Rech-Weichselbraun I, Hinterberger W, et al. Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis. Rheumatol Int 1997;16:181-6.